Harmen van Andel
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Wnt/β-catenin signaling in development and cancer 6
- Mitochondrial Function and Pathology 1
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Steven T. Pals (9 shared papers)Marcel Spaargaren (9 shared papers)Kinga Anna Kocemba-Pilarczyk (5 shared papers)Hans C. Clevers (4 shared papers)Marie José Kersten (6 shared papers)Sander P.J. Joosten (3 shared papers)Marc van de Wetering (2 shared papers)Jurrit Zeilstra (2 shared papers)
- Journals
- Leukemia (2 papers)Oncogene (2 papers)Blood (1 paper)Gastroenterology (1 paper)PLoS ONE (1 paper)
- Partner nations
- NetherlandsPolandCanada
In The Last Decade
Harmen van Andel
11 papers receiving 672 citations
Peers
Comparison fields: 5 of 59
- Hematology 163
- Cell Biology 62
- Molecular Biology 262
- Oncology 81
- Cancer Research 42
Countries citing papers authored by Harmen van Andel
This map shows the geographic impact of Harmen van Andel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmen van Andel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmen van Andel more than expected).
Fields of papers citing papers by Harmen van Andel
This network shows the impact of papers produced by Harmen van Andel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmen van Andel. The network helps show where Harmen van Andel may publish in the future.
Co-authors
The 25 scholars most cited alongside Harmen van Andel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 156 | |
| 2 | 2013 | 119 | |
| 3 | 2017 | 98 | |
| 4 | 2017 | 69 | |
| 5 | 2017 | 47 | |
| 6 | 2016 | 43 | |
| 7 | 2012 | 42 | |
| 8 | 2016 | 41 | |
| 9 | 2013 | 35 | |
| 10 | 2016 | 30 | |
| 11 | 2019 | 3 | |
| 12 | 2025 | 0 |
About Harmen van Andel
Harmen van Andel is a scholar working on Molecular Biology, Hematology, Oncology, Hepatology and Nephrology, having authored 12 papers that have together received 683 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (6 papers), Multiple Myeloma Research and Treatments (2 papers), Immunodeficiency and Autoimmune Disorders (1 paper), Mitochondrial Function and Pathology (1 paper), Viral Infections and Immunology Research (1 paper), Liver physiology and pathology (1 paper), Cancer Cells and Metastasis (1 paper) and Acute Kidney Injury Research (1 paper). The work is most often cited by research in Hematology (163 citations), Cell Biology (62 citations), Molecular Biology (262 citations), Oncology (81 citations) and Cancer Research (42 citations). Harmen van Andel has collaborated with scholars based in Netherlands, Poland and Canada. Frequent co-authors include Steven T. Pals, Marcel Spaargaren, Kinga Anna Kocemba-Pilarczyk, Hans C. Clevers, Marie José Kersten, Sander P.J. Joosten, Marc van de Wetering, Jurrit Zeilstra, Cornelia Tölg and Anton J. M. Berns. Their work appears in journals such as Leukemia, Oncogene, Blood, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.